0
0

Department of Health and Human Services Awarded a Contract to THE INSTITUTE FOR CANCER RESEARCH for $149,995,000.00

Signed on

1/24/2024, 12:00 AM

THE INSTITUTE FOR CANCER RESEARCH Government Contract #75N91024D00003

THE INSTITUTE FOR CANCER RESEARCH was awarded a contract with the United States Government for $149,995,000.00. The contract was awarded by the agency office NIH NCI, which is a division with the National Institutes of Health within the Department of Health and Human Services.

Summary of Award

The recipient of the federal contract is The Institute for Cancer Research based in Philadelphia, Pennsylvania. The contract is an Indefinite Delivery/Indefinite Quantity for preclinical efficacy and intermediate endpoint biomarkers in support of the Prevent Cancer Preclinical Drug Development Program. The contract is funded by the Department of Health and Human Services, specifically the National Institutes of Health, and is worth $149,995,000. No notable spending patterns or transactions are listed.

Contract Details

Contract ID75N91024D00003
Contract TypeIDV_B_B
Total Obligation$0.00
Exercised Options
Base Amount + Options$149,995,000.00
Date Signed2024-01-24
Contract DescriptionPRECLINICAL EFFICACY & INTERMEDIATE ENDPOINT BIOMARKERS IDIQ CONTRACT IN SUPPORT OF THE PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
Start Date2024-01-25
End Date2029-01-24

Agency Details

Awarding AgencyDepartment of Health and Human Services
Awarding Sub AgencyNational Institutes of Health
Awarding OfficeNIH NCI
Funding AgencyDepartment of Health and Human Services
Funding Sub AgencyNational Institutes of Health
Funding OfficeNIH NCI

Recipient Details

RecipientTHE INSTITUTE FOR CANCER RESEARCH
Recipient Location333 COTTMAN AVE PHILADELPHIA PENNSYLVANIA, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Tax Exempt, Nonprofit Organization, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions